ECSP045210A - 2' - halo - 3' , 5' - dialcoxi - fen - 1' - il - imino - 2 -imidazolidinas y su uso como un fármaco - Google Patents

2' - halo - 3' , 5' - dialcoxi - fen - 1' - il - imino - 2 -imidazolidinas y su uso como un fármaco

Info

Publication number
ECSP045210A
ECSP045210A EC2004005210A ECSP045210A ECSP045210A EC SP045210 A ECSP045210 A EC SP045210A EC 2004005210 A EC2004005210 A EC 2004005210A EC SP045210 A ECSP045210 A EC SP045210A EC SP045210 A ECSP045210 A EC SP045210A
Authority
EC
Ecuador
Prior art keywords
halo
imino
imidazolidinas
dialcoxi
fen
Prior art date
Application number
EC2004005210A
Other languages
English (en)
Inventor
Franz Esser
Pascale Pouzet
Naoki Ishiguro
Hisato Kitagawa
Ikunobu Muramatsu
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ECSP045210A publication Critical patent/ECSP045210A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención relaciona a 2' - halo - 3' , 5' - dialcoxifen - 1' - il - imino - 2 -imidazolidinas, el tautomérico 2' - halo - 3' , 5' - dialcoxianilino - 2 - imidazolina y/o las sales farmacéuticamente aceptables del mismo y sus uso como composiciones farmacéuticas en el tratamiento de la incontinencia urinaria (I)
EC2004005210A 2002-01-31 2004-07-28 2' - halo - 3' , 5' - dialcoxi - fen - 1' - il - imino - 2 -imidazolidinas y su uso como un fármaco ECSP045210A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02002352A EP1333028A1 (en) 2002-01-31 2002-01-31 2'-Halo-3',5'-dialkoxyphen-1'-yl-imino-2-imidazolidine derivatives and the use thereof for the treatment of urinary incontinence

Publications (1)

Publication Number Publication Date
ECSP045210A true ECSP045210A (es) 2004-09-28

Family

ID=8185397

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2004005210A ECSP045210A (es) 2002-01-31 2004-07-28 2' - halo - 3' , 5' - dialcoxi - fen - 1' - il - imino - 2 -imidazolidinas y su uso como un fármaco

Country Status (20)

Country Link
EP (2) EP1333028A1 (es)
JP (1) JP2005516066A (es)
KR (1) KR20040074134A (es)
CN (1) CN1617857A (es)
AR (1) AR038380A1 (es)
BR (1) BR0215560A (es)
CA (1) CA2474588A1 (es)
EA (1) EA200400877A1 (es)
EC (1) ECSP045210A (es)
HR (1) HRP20040691A2 (es)
HU (1) HUP0402654A2 (es)
IL (1) IL162776A0 (es)
MX (1) MXPA04007250A (es)
NO (1) NO20043614L (es)
PE (1) PE20030819A1 (es)
PL (1) PL369826A1 (es)
TW (1) TW200418462A (es)
UY (1) UY27628A1 (es)
WO (1) WO2003064398A1 (es)
ZA (1) ZA200405173B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (ja) * 2008-04-16 2008-10-22 国立大学法人福井大学 イミダゾリン誘導体
US20090286829A1 (en) * 2008-05-13 2009-11-19 Allergan, Inc. Quinolynylmethylimidizoles as therapeutic agents
US8258167B2 (en) 2008-05-13 2012-09-04 Allergan, Inc Naphthylmethylimidizoles as therapeutic agents
US8063231B2 (en) * 2008-06-09 2011-11-22 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions
EP2303264B1 (en) * 2008-06-09 2018-04-04 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions using imidazoline derivatives
US9034910B2 (en) 2008-06-09 2015-05-19 Allergan, Inc. Methods of treating alpha adrenergic mediated conditions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2220906A1 (de) * 1972-04-28 1973-11-15 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze sowie verfahren zu deren herstellung
DE2259160A1 (de) * 1972-12-02 1974-06-06 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline, deren saeureadditionssalze und verfahren zur herstellung derselben sowie ihre verwendung als arzneimittel
AT333749B (de) * 1974-07-03 1976-12-10 Chemie Linz Ag Verfahren zur herstellung von neuen 2-arylamino-2-imidazolinderivaten
MTP837B (en) * 1977-11-07 1979-10-22 Hoffman La Roche And Co Aktien Derivatives 2 finino-imidazolidire
DE3514351A1 (de) * 1985-04-20 1986-11-06 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte 2-(n-alkinyl-n-phenyl)amino)-imidazolinderivate, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
SG72827A1 (en) * 1997-06-23 2000-05-23 Hoffmann La Roche Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
DE19740176C2 (de) * 1997-09-12 2000-04-06 Lemfoerder Metallwaren Ag Handschaltvorrichtung für ein Kraftfahrzeug

Also Published As

Publication number Publication date
IL162776A0 (en) 2005-11-20
EP1472231A1 (en) 2004-11-03
PL369826A1 (en) 2005-05-02
KR20040074134A (ko) 2004-08-21
JP2005516066A (ja) 2005-06-02
NO20043614L (no) 2004-08-30
EP1333028A1 (en) 2003-08-06
CA2474588A1 (en) 2003-08-07
ZA200405173B (en) 2005-06-21
BR0215560A (pt) 2004-12-21
EA200400877A1 (ru) 2005-02-24
HRP20040691A2 (en) 2004-12-31
TW200418462A (en) 2004-10-01
UY27628A1 (es) 2003-08-29
CN1617857A (zh) 2005-05-18
AR038380A1 (es) 2005-01-12
HUP0402654A2 (hu) 2005-03-29
MXPA04007250A (es) 2004-10-29
WO2003064398A1 (en) 2003-08-07
PE20030819A1 (es) 2003-10-20

Similar Documents

Publication Publication Date Title
UY27755A1 (es) Nuevas composiciones farmacéuticas basadas en anticolinérgicos e inhibidores.
ECSP034914A (es) "azaindoles"
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
DE60336664D1 (de) Nichtnukleosidische reverse-transkriptase-hemmer
NO20065904L (no) Terapeutiske forbindelser
ECSP066311A (es) Derivados de la piperazina y su uso como agentes terapéuticos
CO5271715A1 (es) 7-aza-indolin-2-onas sustituidas en 4 y su uso como inhibidores de proteiuna quinasa
CO5640037A2 (es) Derivados de la quinazolina para el tratamiento del cancer
CR6726A (es) Compuestos azapoliciclicos condensados con arilo
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
MX2007000028A (es) Derivados de nicotinamida y su uso como agentes terapeuticos.
NO20065878L (no) Terapeutiske forbindelser
BR0316680A (pt) Pirimidinas inibidoras de chk, pdk e akt, sua produção e uso como agentes farmacêuticos
TW200626138A (en) Heterocyclic derivatives and their use as therapeutic agents
AR034213A1 (es) Composiciones de medicamentos sobre la base de agentes anticolinergicos e inhibidores de pde-iv
AR047529A1 (es) Compuestos de quinolina sustituidos
UY27774A1 (es) Inhibidores de metaloproteinas de triaril-oxi-aril-espiropirimidina-2,4,6-triona
UY27759A1 (es) Combinaciones de medicamentos que contienen compuestos heterocíclicos y un nuevo agente anticolinérgico.
UY28356A1 (es) Derivados de benzimidazol, composiciones que los contienen, preparaciones de los mismos y sus usos
WO2006125194A3 (en) Piperazine derivatives and their uses as therapeutic agents
ECSP045397A (es) 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS
ATE389655T1 (de) Pyrimidinderivate
ECSP045210A (es) 2' - halo - 3' , 5' - dialcoxi - fen - 1' - il - imino - 2 -imidazolidinas y su uso como un fármaco
SE0001916D0 (sv) Novel formulation